Pablo Albasanz-García/LinkedIn
Jan 14, 2026, 11:26
Pablo Albasanz-García and Colleagues on Anticancer Treatment-Induced Arterial and Venous Thrombosis
Journal of Thrombosis and Haemostasis (JTH) shared on LinkedIn:
”Mechanisms of anticancer treatment-induced arterial and venous thrombosis
This narrative review explores how cancer therapies trigger blood clots through coagulation activation, vascular damage, tumor cell death materials, and inflammation—crucial for developing better thrombosis prevention strategies.
Authors: Pablo Albasanz-García, Mark Ward, Lucy Norris
Check out this article.”
Article: Mechanisms of anticancer treatment-induced arterial and venous thrombosis
Authors: Pablo Albasanz-García, Mark P. Ward, Lucy A. Norris
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 20, 2026, 06:45Grant Garcia: Why Does a Blood Clot Diagnosis Immediately End an Athlete’s Season?
-
Oct 20, 2026, 06:35Parag Tamhankar: Landmark Study Reveals Genetic Spectrum and Targeted Therapies for ALPS in the Indian Population
-
Oct 20, 2026, 06:26Nina Houben: Neonatal Blood Transfusion Symposium and PhD Defense
-
Oct 20, 2026, 05:46Jan T. Kielstein: DNP Poisoning and Hemoadsorption The Limits of Rescue Therapy
-
Oct 20, 2026, 05:33Giulia Di Paolo: Connecting Plasma Donation to the Patients Who Depend on It
-
Oct 20, 2026, 05:20James Knowles: Exploring Plasma Manufacturing and Strengthening Industry Collaboration
-
Oct 20, 2026, 05:11Giuseppe Lippi։ Understanding Liver Test Abnormalities After AAV Gene Therapy
-
Oct 20, 2026, 05:02Sanam Loghavi: Test Your Hematology Knowledge at ASH 2026!
-
Oct 20, 2026, 04:13Ifeanyichukwu Ifechidere: DOACs Are Not the Answer to Every Anticoagulation Question